...
首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Cloning, expression and purification of the complete domain of the η -carbonic anhydrase from Plasmodium falciparum
【24h】

Cloning, expression and purification of the complete domain of the η -carbonic anhydrase from Plasmodium falciparum

机译:恶性疟原虫η-碳酸酐酶完整结构域的克隆,表达和纯化

获取原文
           

摘要

Abstract The antimalarial drugs are of fundamental importance in the control of malaria, especially for the lack of efficient treatments and acquired resistance to the existing drugs. For this reason, there is a continuous work in identifying novel, less toxic and effective chemotherapies as well as new therapeutic targets against the causative agents of malaria. In this context, a superfamily of metalloenzymes named carbonic anhydrases (CAs, EC 4.2.1.1) has aroused a great interest as druggable enzymes to limit the development of Plasmodium falciparum gametocytes. CAs catalyze a common reaction in all life domains, the carbon dioxide hydration to bicarbonate and protons (CO2?+?H2O ? HCO3-?+?H+). P. falciparum synthesizes pyrimidines de novo starting from HCO3-, which is generated from CO2 through the action of the η-CA identified in the genome of the protozoan. Here, we propose a procedure for the preparation of a wider portion of the protozoan η-CA, named PfCAdom (358 amino acid residues), with respect to the truncated form prepared by Krungkrai et al. (PfCA1, 235 amino acid residues). The results evidenced that the recombinant PfCAdom, produced as a His-tag fusion protein, was 2.7 times more active with respect the truncated form PfCA1.
机译:摘要抗疟药在控制疟疾方面具有根本的重要性,特别是由于缺乏有效的治疗方法和对现有药物产生抗药性。由于这个原因,在鉴定新的,毒性较小和有效的化学疗法以及针对疟疾的致病因子的新治疗靶标方面正在进行持续的工作。在这种情况下,被称为碳酸酐酶(CAs,EC 4.2.1.1)的金属酶超家族引起了人们极大的兴趣,因为它们是可药用的酶来限制恶性疟原虫配子体细胞的发育。 CA催化所有生命域中的常见反应,即二氧化碳水合成碳酸氢根和质子(CO 2 ?+?H 2 O?HCO 3 -?+?H + )。恶性疟原虫从HCO 3 -开始重新合成嘧啶,HCO 3 -是通过CO 2 通过在原生动物的基因组。在这里,相对于由Krungkrai等人制备的截短形式,我们提出了一种制备更宽范围的原生动物η-CA的方法,称为PfCAdom(358个氨基酸残基)。 (PfCA1,235个氨基酸残基)。结果证明,作为His标签融合蛋白生产的重组PfCAdom的活性是截短形式的PfCA1的2.7倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号